These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7893260)
1. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route. Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of 14C-moxisylyte after percutaneous application in hairless rat. Neau B; Roux J; Marty JP Arzneimittelforschung; 1998 Jan; 48(1):34-8. PubMed ID: 9522028 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat. Neau B; Roux J; Courtiol C; Lambrey B; Marty JP Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of thymoxamine. II. Studies with 14C-thymoxamine in man. Vollmer KO; Poisson A Eur J Drug Metab Pharmacokinet; 1985; 10(1):71-6. PubMed ID: 3161739 [TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of 14C-thymoxamine in rat and man. Duchene P; Bernouillet C; Bromet-Petit M; Mosser J; Feniou C; Gaudin D; Virelizier H Xenobiotica; 1988 Aug; 18(8):919-28. PubMed ID: 2973182 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
9. Microbial models of mammalian metabolism. Fungal metabolism of phenolic and nonphenolic p-cymene-related drugs and prodrugs. I. Metabolites of thymoxamine. Moussa C; Houziaux P; Danree B; Azerad R Drug Metab Dispos; 1997 Mar; 25(3):301-10. PubMed ID: 9172947 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and excretion of 14C-tiropramide after single intravenous or peroral administration to the rat. Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G Arzneimittelforschung; 1989 Mar; 39(3):328-34. PubMed ID: 2757659 [TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a prodrug thymoxamine: dose-dependence of the metabolite ratio in healthy subjects. Marquer C; Trouvin JH; Lacolle JY; Dupont C; Jacquot C Eur J Drug Metab Pharmacokinet; 1991; 16(3):183-8. PubMed ID: 1839981 [TBL] [Abstract][Full Text] [Related]
14. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
15. [The pharmacokinetics of Z-2-amino-5-chlorobenzophenoneamidinohydrazone in the rat]. Schieweck A; offchert HH; Morgenroth U; Joram U Pharmazie; 1993 May; 48(5):370-3. PubMed ID: 8327566 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309 [TBL] [Abstract][Full Text] [Related]
17. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)]. Niebch G; Obermeier K; Vergin H; Thiemer K Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829 [TBL] [Abstract][Full Text] [Related]
18. Tiropramide and metabolites in blood and plasma after intravenous or peroral administration of 14C-tiropramide to the rat. Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G Arzneimittelforschung; 1988 Dec; 38(12):1815-9. PubMed ID: 3245854 [TBL] [Abstract][Full Text] [Related]
19. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875 [TBL] [Abstract][Full Text] [Related]
20. Disposition of the opioid antagonist, LY255582, in rats and dogs. Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]